Twelve-month findings showed favorable and consistent trends for participants receiving SKY-0515 across all four cUHDRS ...
(NYSE: EVMN) (the “Company” or “Evommune”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced top-line ...
EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...
The City Council chose an incremental approach to the charges, which are meant to offset the impact of housing production on ...
The FDA plans to hold an advisory committee meeting to discuss Capricor Therapeutics’ application for deramiocel, which the agency rejected last July. The news surprised CEO Linda Marbán, who told ...
A study published in Nature Physics provides new molecular-level evidence from simulations that liquid water is not a single uniform substance, but a constantly shifting mixture of two distinct ...
When Santa Cruz Metro was forced to confront bleak financial forecasts in 2008, 2012 and 2016, the solution was the same.